Elisa Herráez

Expression of Slc22a1 Variants May Affect the Response of Hepatocellular Carcinoma And Cholangiocarcinoma To Sorafenib

Elisa Herráez, Elisa Lozano, Rocı́o I.R. Macı́as et al. · Hepatology · 2013 · 142 citations · Full text

Medicine, Genetics, Oncology +14

Cocarcinogenic Effects of Intrahepatic Bile Acid Accumulation in Cholangiocarcinoma Development

Elisa Lozano, Laura Sanchez‐Vicente, María J. Monte et al. · Molecular Cancer Research · 2013 · 78 citations

Pharmacy, Pathobiology, Toxicology +17

Cisplatin-Induced Chemoresistance in Colon Cancer Cells Involves FXR-Dependent and FXR-Independent Up-Regulation of ABC Proteins

Elisa Herráez, Ester Gonzalez‐Sanchez, Javier Vaquero et al. · Molecular Pharmaceutics · 2012 · 65 citations

Medicine, Oncology, Pharmacology +11

ACOX2 deficiency: An inborn error of bile acid synthesis identified in an adolescent with persistent hypertransaminasemia

María J. Monte, Marta Alonso‐Peña, Óscar Briz et al. · Journal of Hepatology · 2016 · 59 citations

Life Sciences, Biochemistry, Pediatrics +17

Activation of the nuclear receptor FXR enhances hepatocyte chemoprotection and liver tumor chemoresistance against genotoxic compounds

Javier Vaquero, Óscar Briz, Elisa Herráez et al. · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · 2013 · 57 citations

Medicine, Oncology, Pharmacology +12